Table 2 Comparison of the clinicopathologic characteristics in patients
Parameter | Relapse | ||
|---|---|---|---|
(+) (N = 10) | (−) (N = 22) | P value | |
Age (years old) | 61.6 ± 3.6 | 60.5 ± 2.4 | 0.799 |
Gender (male) | 8 | 18 | 0.732 |
Imaging of pancreatic parenchyma (Diffuse) | 8 | 15 | 0.897 |
IgG (mg/dl) | 2020 ± 298 | 1877 ± 205 | 0.398 |
IgG4 (mg/dl) | 525 ± 124 | 368 ± 84 | 0.483 |
Obstructive jaundice | 4 | 9 | 0.560 |
Bile duct stricturea | 8 | 17 | 0.795 |
Extra-pancreatic lesionsb | 2 | 4 | 0.988 |
Diabetes | 5 | 15 | 0.268 |
Pre-treatment pancreatic volume (cm3) | 92.6 ± 10.5 | 86.6 ± 7.1 | 0.401 |
Post-treatment pancreatic volume (cm3) | 56.9 ± 6.3 | 40.2 ± 4.2 | 0.008* |
Percent reduction of pancreatic volume (%) | 36.6 ± 4.7 | 52.1 ± 3.2 | 0.002* |
Pre-treatment splenic volume (cm3) | 133.9 ± 18.9 | 135.0 ± 12.7 | 0.959 |
Post-treatment splenic volume (cm3) | 116.5 ± 16.5 | 116.0 ± 11.1 | 0.836 |
Percent reduction of splenic volume (%) | 13.5 ± 6.3 | 12.3 ± 4.2 | 0.616 |